Cited by 182Chemotherapy-induced cardiotoxicity and mitigationProtease and Inhibitor MechanismsCardiac Fibrosis and Remodeling

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase

SPALLAROSSA, P, ALTIERI, P, GARIBALDI, S, GHIGLIOTTI, G, BARISIONE, C, MANCA, V, FABBI, P, BALLESTRERO, A +2 more·2006·Cardiovascular Research

Abstract

OBJECTIVE: Dysregulation of myocardial metalloproteinases (MMPs) is now regarded as an early contributory mechanism for the initiation and progression of heart failure. Doxorubicin is a strongly cardiotoxic anticancer drug. This study investigates the effects of doxorubicin on myocardial MMP-2 and MMP-9 activation. METHODS: After pre-treatment with or without carvedilol or dexrazoxane, we exposed H9c2 cardiomyocytes to doxorubicin to evaluate reactive oxygen species (ROS) formation and MMP-2 and MMP-9 expression and activation. To investigate the signaling pathways leading to doxorubicin-induced MMP activation, we also examined the phosphorylation of three members of the MAPK family (ERK1/2, p38, and JNK), the effects of selective inhibitors of ERK1/2, p38, and JNK on MMP transcription and activity, the transcription of the NAD(P)H oxidase subunit Nox1, and the effects of the NAD(P)H oxidase inhibitor DPI on MMP activation. RESULTS: Doxorubicin induces a significant increase in ROS formation and a rapid increase of MMP expression and activation. Pre-treatment with carvedilol or dexrazoxane prevented these effects. We also found that p38 is the MAPK that is mainly responsible for MMP-9 activation through an NAD(P)H-independent mechanism. ERK and JNK modulate the transcription of the NAD(P)H oxidase subunit Nox1, while the JNK/ERK NAD(P)H oxidase cascade is an important pathway that mediates doxorubicin signaling to MMP-2. Inhibition of NAD(P)H oxidase attenuates the increase in MMP-2, but augments the doxorubicin-induced increase in MMP-9. CONCLUSIONS: Enhancement of MMP-2 and MMP-9 in cardiac myocytes in response to doxorubicin is mediated by the cooperation of ERK, JNK, and p38 kinase pathways, most of which are redox dependent.

Integrity signals

Registry

Crossref · 10.1016/j.cardiores.2005.08.009

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tyrosines for which the aromatic ring is closer to the surface of a protein, in which there is a neighboring negative charge, and those in hydrophobic regions are more likely to be nitrated.

    “Tyrosines for which the aromatic ring is closer to the surface of a protein, in which there is a neighboring negative charge, and those in hydrophobic regions are more likely to be nitrated (66, 877).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
SPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A.
Affiliations
University of Genoa (IT)
Corresponding author
ALTIERI, P
Venue
Cardiovascular Research
Published
2006-02-15
Volume
69
Issue
3
Pages
736-745
ISSN
0008-6363 (ISSN-L)
OpenAlex
W2153709731
Cited by
182
References
44
Citations by year
2026: 1 · 2025: 9 · 2024: 6 · 2023: 15 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 7 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 11 · 2013: 11 · 2012: 9
FWCI
4.34
Type
journal article
Language
en
Open access
closed
Locations
  • Cardiovascular Research (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
doxorubicin, cardiotoxicity, MMP-2, MMP-9, MAPK signaling, p38 MAPK, ERK1/2, JNK, NADPH oxidase, NOX1, reactive oxygen species, carvedilol, dexrazoxane, H9c2 cells, heart failure, redox signaling
MeSH terms
Carvedilol, Anthracenes, Antibiotics, Antineoplastic, Antioxidants, Carbazoles, Catecholamines, Cell Line, Doxorubicin, Enzyme Activation, Flavonoids, Humans, Imidazoles, Propanolamines, Protein-Tyrosine Kinases, Pyridines, Razoxane, Blotting, Western, NADPH Oxidases, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Myocytes, Cardiac, p38 Mitogen-Activated Protein Kinases, Imidazolines, Janus Kinase 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review